236O Olaparib (ola) plus bevacizumab (bev) as maintenance (mx) therapy in patients (pts) with newly diagnosed advanced ovarian carcinoma (OC): Japan subset of the PAOLA-1 trial
2020 ◽
Vol 31
◽
pp. S1335-S1336
K. Fujiwara
◽
H. Fujiwara
◽
H. Yoshida
◽
T. Satoh
◽
K. Yonemori
◽
...
2010 ◽
Vol 116
(3)
◽
pp. 483-488
◽
John P. Diaz
◽
Nadeem R. Abu-Rustum
◽
Yukio Sonoda
◽
Robert J. Downey
◽
Bernard J. Park
◽
...
2006 ◽
Vol 2006
◽
pp. 470-472
2006 ◽
Vol 2006
◽
pp. 161-162
N. Colombo
◽
J.A. Ledermann
1988 ◽
Vol 30
(3)
◽
pp. 347-358
◽
A.Peter M. Heintz
◽
Allan T. Van Oosterom
◽
J.Baptist M.C. Trimbos
◽
Aart Schaberg
◽
Edo A. Van Der Velde
◽
...
2008 ◽
Vol 111
(2)
◽
pp. 380-381
D.M. Chase
◽
A. Rincon
◽
M. Deane
◽
K.S. Tewari
◽
W.R. Brewster
1994 ◽
Vol 55
(3)
◽
pp. S97-S107
◽
Tate Thigpen
◽
Ralph Vance
◽
Louis Puneky
◽
Tawfiq Khansur
Sakari Hietanen
◽
Patricia Pautier
◽
Philipp Harter
◽
Claire Cropet
◽
Saverio Cinieri
◽
...
1976 ◽
Vol 4
(1)
◽
pp. 43-52
◽
Hans E. Geisler
◽
James R. Minor
◽
Marvin E. Eastlund
Close
Export Citation Format
Close
Share Document
Close